Gustave Roussy is a non-profit making private health establishment with a public role.
As a Cancer Centre, its status derives from Directive n° 45-2221 of the 1st October 1945, modified by Directive n° 2005-406 of the 2nd May 2005 and by the "HPST" Law of 21st July 2009 on hospital reform with a bearing on patients, health and local authorities. 

Gustave Roussy is a member of Unicancer, an organisation to which all French Cancer Centres belong.

International Thoracic Cancer Center Staff

Gustave Roussy

• Fabrice Barlesi, General Director of Gustave Roussy, medical oncologist
• David Planchard, thoracic oncologist, chairman of the thoracic cancer commitee of Gustave Roussy and president of the International Thoracic Cancer Center
• Benjamin Besse, medical oncologist, director of clinical research at Gustave Roussy

Lung cancer treatment

Patients with lung, pleural or mediastinal cancer may be offered different treatments, depending on the type of cancer and its spread or stage at the time of diagnosis. Treatments may be combined during therapy.

Local treatments

Surgery

Management of lung cancer

• Adult bronchopulmonary cancers: non-small cell and small cell carcinomas
• Pleural tumours: mesothelioma and others
• Mediastinal tumours: thymoma and others
• Pleuropulmonary metastases requiring local treatment (committee-coordinated management depending on the primary tumour site)

The International Thoracic Cancer Centre

Vos questions, nos réponses

Compliqué, le legs ? Bien moins que nous le pensons généralement. Mais le caractère bien spécifique de ce mode de soutien soulève beaucoup de questions. Voici les réponses aux interrogations les plus courantes que vous apporte notre responsable legs, Caroline de Clermont-Tonnerre.